Ftse Mib
36.267,63
1,25%
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
103.123,25
-0,96%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Perspective Therapeutics Inc (CATX) Perspective Therapeutics Inc (CATX) Notizie

Perspective Therapeutics Inc

CATX
3,46
0,30 (9,49%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202514:36EDGAR2Form 8-K - Current report
13/1/202514:00GLOBEPerspective Therapeutics Provides Business Updates and..
10/1/202513:00GLOBEPerspective Therapeutics to Present at the 43rd Annual J.P...
07/1/202522:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202522:48EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/1/202514:05EDGAR2Form 8-K - Current report
06/1/202514:00GLOBEPerspective Therapeutics Appoints Juan Graham, MBA as Chief..
06/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202423:17EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
27/11/202413:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202413:00GLOBEPerspective Therapeutics to Participate in Upcoming Investor..
26/11/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202413:30EDGAR2Form 8-K - Current report
21/11/202413:15GLOBEPerspective Therapeutics to Pursue Dose Escalation of..
15/11/202422:08GLOBEPerspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET..
15/11/202413:30EDGAR2Form 8-K - Current report
15/11/202400:14EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202422:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202416:24EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
12/11/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:07EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEPerspective Therapeutics Provides Recent Business Highlights..
31/10/202412:00GLOBEPerspective Therapeutics to Provide Business Highlights and..
29/10/202412:00GLOBEPerspective Therapeutics to Participate in Upcoming Investor..
23/10/202413:00GLOBEPerspective Therapeutics Presents Updates at the 37th Annual..
16/10/202413:00GLOBEPerspective Therapeutics Begins Shipping Investigational..
11/10/202414:31EDGAR2Form 8-K - Current report
11/10/202414:30GLOBEPerspective Therapeutics to Advance Investigation of..
10/10/202423:14GLOBEPerspective Therapeutics to Present at the 21st..
07/10/202413:00GLOBEPerspective Therapeutics to Participate at the Oppenheimer..
30/9/202413:00GLOBEPerspective Therapeutics to Present at the 37th Annual..
10/9/202413:00GLOBEPerspective Therapeutics Presents at the World Molecular..
05/9/202413:00GLOBEPerspective Therapeutics Granted Fast Track Designation for..
28/8/202413:00GLOBEPerspective Therapeutics to Participate in Upcoming Investor..
13/8/202411:39IHMARKETNEWSRumble Shares Up 7% in Premarket After 27% Q2 Revenue Surge;..
12/8/202422:05GLOBEPerspective Therapeutics Provides Recent Business Highlights..
12/8/202411:47IHMARKETNEWSU.S. Futures Steady as Markets Await Key Inflation Data, Oil..
30/7/202413:00GLOBEPerspective Therapeutics to Participate at Upcoming Investor..
22/7/202413:00GLOBEPerspective Therapeutics to Provide Business Highlights..
12/6/202413:00GLOBEPerspective Therapeutics Announces Inclusion in the Russell..
11/6/202413:00GLOBEPerspective Therapeutics Announces 1-for-10 Reverse Stock..
10/6/202422:10GLOBEPerspective Therapeutics Presents at the Society of Nuclear..
24/5/202414:01GLOBEPerspective Therapeutics Announces Pricing of $80 Million..
20/5/202413:00GLOBEPerspective Therapeutics to Present at the Society of..
15/5/202413:00GLOBEPerspective Therapeutics Provides Recent Business Highlights..
03/5/202413:00GLOBEPerspective Therapeutics to Participate at Upcoming May..
02/5/202413:00GLOBEPerspective Therapeutics to Provide Recent Business..
30/4/202413:00GLOBEPerspective Therapeutics Selected by FDA to Participate in..
Apertura: 3,18 Min: 3,10 Max: 3,45
Chiusura: 3,16

La tua Cronologia

AMEX
CATX
Perspective Therapeutics
BIT
XMGA
Amundi Msci Ex Usa Mega ...
BIT
FEUR
Fidelity Sus Re Enh Eur ...
BTRX
XDNUSDT
DigitalNote
AQSE
FGQI.GB
FIL Fund Management Irel...
TG
A19TQY
Aeroports de Paris
BOV
TEKA4M
TEKA PN
TG
A28ZVH
NEPI Rockcastle
LSE
0ECC
Selected Textile Industr...
BIT
DIA
DiaSorin
LBNK
ZIQUSDT
ZIQ
LSE
BM60
Citi Fun 27
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network